Short-chain fatty acid enemas
Autor: | Anthony J. Senagore, John M. MacKeigan, J. Stephen Ebrom, Michael Scheider |
---|---|
Rok vydání: | 1992 |
Předmět: |
Adult
Male medicine.medical_specialty Hydrocortisone medicine.drug_class Cost-Benefit Analysis medicine.medical_treatment Enema Proctosigmoiditis Proctocolitis digestive system Gastroenterology law.invention Randomized controlled trial law Internal medicine medicine Humans Prospective Studies Mesalamine Prospective cohort study Proctitis Chemotherapy business.industry General Medicine Middle Aged Fatty Acids Volatile medicine.disease digestive system diseases Colorectal surgery Aminosalicylic Acids Corticosteroid Female business |
Zdroj: | Diseases of the Colon & Rectum. 35:923-927 |
ISSN: | 0012-3706 |
DOI: | 10.1007/bf02253492 |
Popis: | The purpose of this study was to perform a randomized, prospective comparison of corticosteroid enemas (CS--100 mg of hydrocortisone/60 cc P.R. q.h.s.; n = 12), mesalamine enemas (5-ASA--4 g/60 cc P.R. q.h.s.; n = 19), and short-chain fatty acid enemas (SCFA--60 cc P.R. b.i.d.; n = 14) for the treatment of proctosigmoiditis. Patients presenting to the Ferguson Clinic with the diagnosis of idiopathic proctosigmoiditis were evaluated for age, sex, prior history of proctitis, duration of symptoms prior to presentation, endoscopic scoring, and mucosal biopsies. Clinical evaluation was performed at two-week intervals for six weeks, with repeat biopsies taken at six weeks. There was no significant difference with respect to age, male/female ratio, past history of proctosigmoiditis, length of colorectum involved at the time of initial presentation, symptom resolution, and endoscopic and histologic improvement among the three treatment groups. Recovery occurred in a similar proportion in each of the three groups: CS, 10/12; 5-ASA, 17/19; and SCFA, 12/14. The cost of six weeks of treatment was: CS, $71.82; 5-ASA, $347.28; and SCFA, $31.50. This study indicates that SCFA enemas are equally efficacious to CS or 5-ASA enemas for the treatment of proctosigmoiditis at a significant cost savings. |
Databáze: | OpenAIRE |
Externí odkaz: |